Orodispersible tablets

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9623010
SERIAL NO

12680296

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to a an orally disintegrating tablet obtainable by direct compression of a dry powdered mixture, said mixture comprising up to 15% by weight of calcium silicate, at least 50% of a diluent, a disintegrant agent and an active ingredient. It also relates to a process for preparing the tablets by homogeneous blending the specific excipients in powder form and subsequent direct compression of the mixture. Said tablets disintegrate quickly in the cavity of the mouth, in particular in less than 15 seconds.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NEURAXPHARM PHARMACEUTICALS S LAVDA BARCELONA 69 SANT JOAN DESPÍ 08970

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Úbeda, Pérez Carmen Cabrils-Barcelona, ES 4 87
Díez, Martín Ignacio Sant Feliu de Llobregat-Barcelona, ES 4 87
Pablo, Alba Pablo Cornella de Llobregat-Barcelona, ES 4 87

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 18, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00